Demant


Factoring in innovation and the market recovery

08/10/26 -"Our target price has increased due to a higher NAV and DCF, along with a 20% premium applied to our peer-based valuation metrics, excluding dividend yield. This positive outlook is supported by ..."

Pages
71
Language
English
Published on
08/10/26
You may also be interested by these reports :
08/10/26
Our target price has increased due to a higher NAV and DCF, along with a 20% premium applied to our peer-based valuation metrics, excluding dividend ...

08/10/26
The TP increase reflects upgrades to our DCF and NAV (discussed above). The investment case remains compelling: consumables-led growth, the ...

08/10/26
Beaten down, not broken.

05/10/26
When we last teased on Fresenius (BUY; Germany) in May 2025, the story was about slimming down: shedding Vamed, deconsolidating FMC and working the ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO